$DTHR Dthera Sciences Chief Executive Officer, Edw

$DTHR Dthera Sciences Chief Executive Officer, Edward Cox, stated, "2017 was a meaningful year for Dthera as we advanced our digital therapeutic platform significantly in the lead up to the planned launch of our first product in 2018. Our digital platform has the potential to democratize effective practices, such as reminiscence therapy, that are currently impossible to scale, and make them more accessible to millions suffering from conditions such as social isolation and dementia. Importantly, we believe the benefits may also extend to caregivers, empowering them to better meet the needs of their loved ones, and potentially easing the burden of care, while providing greater peace of mind. Dthera plans to launch its first product, ReminX™, a tablet-based consumer health product designed to deliver personalized reminiscence therapy, in the second quarter of 2018."

https://finance.yahoo.com/news/uipath-set-hos...00309.html

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!